CagriSema dose calculator

Reported study range for weight management (investigational Phase 3 dose): 2400–2400 mcg once weekly (subcutaneous). Convert it below, including draw volume and syringe units.

Convert your CagriSema dose

Amount

From

To

Vial

Vial amount (mg)

Diluent volume (mL)

Result

Converted amount2,400 mcg

Dose mass2,400 mcg

Concentration2,500 mcg/mL

Draw volume0.96 mL

U-100 syringe96 units

Reported study ranges

Purpose	Route	Reported range	Frequency
weight management (investigational Phase 3 dose)	subcutaneous	2400–2400 mcg	once weekly

Ranges are reported from the literature for research context only. They are not a protocol and not a recommendation.

Concentration by vial and diluent

Vial	1 mL diluent	2 mL diluent	3 mL diluent
2 mg	2,000 mcg/mL	1,000 mcg/mL	667 mcg/mL
5 mg	5,000 mcg/mL	2,500 mcg/mL	1,667 mcg/mL
10 mg	10,000 mcg/mL	5,000 mcg/mL	3,333 mcg/mL

Concentration is vial mass divided by diluent volume. Reconstitution volume changes what you draw, never the dose itself.

What to draw for 2,400 mcg

Vial	Diluent	Draw volume	U-100 units	Doses per vial
2 mg	1 mL	1.2 mL	120 units	1
2 mg	2 mL	2.4 mL	240 units	1
2 mg	3 mL	3.6 mL	360 units	1
5 mg	1 mL	0.48 mL	48 units	2
5 mg	2 mL	0.96 mL	96 units	2
5 mg	3 mL	1.44 mL	144 units	2
10 mg	1 mL	0.24 mL	24 units	4
10 mg	2 mL	0.48 mL	48 units	4
10 mg	3 mL	0.72 mL	72 units	4

Calculated for the low end of the reported weight management (investigational Phase 3 dose) range. Change the dose in the calculator above for any other amount.

CagriSema at a glance

~7 days (semaglutide component); cagrilintide ~7 days — both designed for weekly dosing

Half-life

Not established

Molecular weight — molar conversion unavailable

subcutaneous

Routes

research only

Legal status

Full CagriSema profile →All dose calculators →